fbpx

Welcome! We just launched the new Life Science and Food Industry Podcasts. Available everywhere!

X

Xtalks Voices: Magnus Medical CEO Dr. Brett Wingeier Talks About Neurostimulation for Depression – Xtalks Life Science Podcast Ep. 37

Xtalks Voices: Magnus Medical CEO Dr. Brett Wingeier Talks About Neurostimulation for Depression – Xtalks Life Science Podcast Ep. 37

In this episode, the editorial team spoke with Dr. Brett Wingeier, CEO of neuromodulation MedTech Magnus Medical, about the company’s Magnus System for the treatment of major depressive disorder (MDD). The neurostimulation device received breakthrough device designation from the US Food and Drug Administration (FDA) last month. The team heard from Dr. Wingeier about the challenges of treating depression and how neuromodulation shows clinical effectiveness in treating the condition. Given this, he explained how the company decided to develop the Magnus System and described how it works. As a 20-year veteran in the field of neuromodulation, hear Dr. Wingeier’s insights into how the field has grown over the last two decades and its continuing growth in the future.

Listen on Apple Podcasts

Read the full article here:

Magnus Medical’s Neurostimulation Technology Granted FDA Breakthrough Device Designation

The weekly podcast is available for streaming every Wednesday on SpotifyApple Music and wherever you stream your podcasts.

Subscribe to the Xtalks Life Science Podcast to never miss a new episode.